Read + Share
Amedeo Smart
Independent Medical Education
Kohlmorgen C, Gerfer S, Feldmann K, Twarock S, et al. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus. Diabetologia 2021;64:1834-1849.PMID: 34131781
Email
LinkedIn
Facebook
Twitter
Privacy Policy